BETTY LAMOTHE

TitleAssistant Professor
InstitutionMD Anderson
DepartmentExperimental Therapeutics
Address1901 East Road
Houston TX 77054-3005
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Abou Dalle I, Cortes JE, Pinnamaneni P, Lamothe B, Diaz Duque A, Randhawa J, Pemmaraju N, Jabbour E, Ferrajoli A, Wierda WG, Estrov Z, Konopleva M, Ravandi F, Alvarado Y, Borthakur G, Gandhi V, Kantarjian HM. A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia. Acta Haematol. 2018; 140(1):30-39. PMID: 30071517.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    2. Lamothe B, Wierda WG, Keating MJ, Gandhi V. Carfilzomib Triggers Cell Death in Chronic Lymphocytic Leukemia by Inducing Proapoptotic and Endoplasmic Reticulum Stress Responses. Clin Cancer Res. 2016 Sep 15; 22(18):4712-26. PMID: 27026200.
      Citations: 8     Fields:    Translation:HumansCells
    3. Cervantes-Gomez F, Lamothe B, Woyach JA, Wierda WG, Keating MJ, Balakrishnan K, Gandhi V. Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia. Clin Cancer Res. 2015 Aug 15; 21(16):3705-15. PMID: 25829398.
      Citations: 72     Fields:    Translation:HumansCells
    4. Lamothe B, Cervantes-Gomez F, Sivina M, Wierda WG, Keating MJ, Gandhi V. Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemia. Blood. 2015 Jan 08; 125(2):407-10. PMID: 25573971.
      Citations: 12     Fields:    Translation:HumansCells
    5. Lamothe B, Lai Y, Hur L, Orozco NM, Wang J, Campos AD, Xie M, Schneider MD, Lockworth CR, Jakacky J, Tran D, Ho M, Dawud S, Dong C, Lin HK, Hu P, Estrov Z, Bueso-Ramos CE, Darnay BG. Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in mice. PLoS One. 2012; 7(12):e51228. PMID: 23251462.
      Citations: 19     Fields:    Translation:AnimalsCells
    6. Lamothe B, Lai Y, Xie M, Schneider MD, Darnay BG. TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis. Mol Cell Biol. 2013 Feb; 33(3):582-95. PMID: 23166301.
      Citations: 43     Fields:    Translation:AnimalsCells
    7. Wu CY, Kang HY, Yang WL, Wu J, Jeong YS, Wang J, Chan CH, Lee SW, Zhang X, Lamothe B, Campos AD, Darnay BG, Lin HK. Critical role of monoubiquitination of histone H2AX protein in histone H2AX phosphorylation and DNA damage response. J Biol Chem. 2011 Sep 02; 286(35):30806-30815. PMID: 21690091.
      Citations: 34     Fields:    Translation:HumansAnimalsCells
    8. Yin Q, Lamothe B, Darnay BG, Wu H. Structural basis for the lack of E2 interaction in the RING domain of TRAF2. Biochemistry. 2009 Nov 10; 48(44):10558-67. PMID: 19810754.
      Citations: 47     Fields:    Translation:HumansCells
    9. Yang WL, Wang J, Chan CH, Lee SW, Campos AD, Lamothe B, Hur L, Grabiner BC, Lin X, Darnay BG, Lin HK. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science. 2009 Aug 28; 325(5944):1134-8. PMID: 19713527.
      Citations: 260     Fields:    Translation:HumansAnimalsCells
    10. Yin Q, Lin SC, Lamothe B, Lu M, Lo YC, Hura G, Zheng L, Rich RL, Campos AD, Myszka DG, Lenardo MJ, Darnay BG, Wu H. E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol. 2009 Jun; 16(6):658-66. PMID: 19465916.
      Citations: 156     Fields:    Translation:HumansCells
    11. Lamothe B, Campos AD, Webster WK, Gopinathan A, Hur L, Darnay BG. The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. J Biol Chem. 2008 Sep 05; 283(36):24871-80. PMID: 18617513.
      Citations: 41     Fields:    Translation:HumansAnimalsCells
    12. Wu J, Meng F, Kong LY, Peng Z, Ying Y, Bornmann WG, Darnay BG, Lamothe B, Sun H, Talpaz M, Donato NJ. Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase. J Natl Cancer Inst. 2008 Jul 02; 100(13):926-39. PMID: 18577747.
      Citations: 54     Fields:    Translation:HumansAnimalsCells
    13. Lin SC, Chung JY, Lamothe B, Rajashankar K, Lu M, Lo YC, Lam AY, Darnay BG, Wu H. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20. J Mol Biol. 2008 Feb 15; 376(2):526-40. PMID: 18164316.
      Citations: 69     Fields:    Translation:HumansCells
    14. Lamothe B, Webster WK, Gopinathan A, Besse A, Campos AD, Darnay BG. TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem Biophys Res Commun. 2007 Aug 10; 359(4):1044-9. PMID: 17572386.
      Citations: 53     Fields:    Translation:HumansAnimalsCells
    15. Darnay BG, Besse A, Poblenz AT, Lamothe B, Jacoby JJ. TRAFs in RANK signaling. Adv Exp Med Biol. 2007; 597:152-9. PMID: 17633024.
      Citations: 30     Fields:    Translation:HumansAnimalsCells
    16. Besse A, Lamothe B, Campos AD, Webster WK, Maddineni U, Lin SC, Wu H, Darnay BG. TAK1-dependent signaling requires functional interaction with TAB2/TAB3. J Biol Chem. 2007 Feb 09; 282(6):3918-28. PMID: 17158449.
      Citations: 58     Fields:    Translation:HumansAnimalsCells
    17. Lamothe B, Besse A, Campos AD, Webster WK, Wu H, Darnay BG. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. J Biol Chem. 2007 Feb 09; 282(6):4102-12. PMID: 17135271.
      Citations: 161     Fields:    Translation:HumansAnimalsCells
    18. Mattoon DR, Lamothe B, Lax I, Schlessinger J. The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway. BMC Biol. 2004 Nov 18; 2:24. PMID: 15550174.
      Citations: 63     Fields:    Translation:AnimalsCells
    19. Lamothe B, Yamada M, Schaeper U, Birchmeier W, Lax I, Schlessinger J. The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway. Mol Cell Biol. 2004 Jul; 24(13):5657-66. PMID: 15199124.
      Citations: 27     Fields:    Translation:AnimalsCells
    20. Baudry A, Jackerott M, Lamothe B, Kozyrev SV, Leroux L, Durel B, Saint-Just S, Joshi RL. Partial rescue of insulin receptor-deficient mice by transgenic complementation with an activated insulin receptor in the liver. Gene. 2002 Oct 16; 299(1-2):219-25. PMID: 12459269.
      Citations: 1     Fields:    Translation:Animals
    21. Lax I, Wong A, Lamothe B, Lee A, Frost A, Hawes J, Schlessinger J. The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors. Mol Cell. 2002 Oct; 10(4):709-19. PMID: 12419216.
      Citations: 41     Fields:    Translation:HumansAnimalsCells
    22. Ye H, Arron JR, Lamothe B, Cirilli M, Kobayashi T, Shevde NK, Segal D, Dzivenu OK, Vologodskaia M, Yim M, Du K, Singh S, Pike JW, Darnay BG, Choi Y, Wu H. Distinct molecular mechanism for initiating TRAF6 signalling. Nature. 2002 Jul 25; 418(6896):443-7. PMID: 12140561.
      Citations: 207     Fields:    Translation:HumansAnimalsCells
    23. Mukhopadhyay A, Shishodia S, Suttles J, Brittingham K, Lamothe B, Nimmanapalli R, Bhalla KN, Aggarwal BB. Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptors. J Biol Chem. 2002 Aug 23; 277(34):30622-8. PMID: 12060665.
      Citations: 4     Fields:    Translation:HumansCells
    24. Wong A, Lamothe B, Lee A, Schlessinger J, Lax I, Li A. FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl. Proc Natl Acad Sci U S A. 2002 May 14; 99(10):6684-9. PMID: 11997436.
      Citations: 41     Fields:    Translation:HumansAnimalsCells
    25. Majumdar S, Lamothe B, Aggarwal BB. Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester. J Immunol. 2002 Mar 15; 168(6):2644-51. PMID: 11884428.
      Citations: 32     Fields:    Translation:HumansCells
    26. Lamothe B, Aggarwal BB. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60. J Interferon Cytokine Res. 2002 Feb; 22(2):269-79. PMID: 11911810.
      Citations: 10     Fields:    Translation:HumansCells
    27. Jackerott M, Baudry A, Lamothe B, Bucchini D, Jami J, Joshi RL. Endocrine pancreas in insulin receptor-deficient mouse pups. Diabetes. 2001 Feb; 50 Suppl 1:S146-9. PMID: 11272177.
      Citations: 6     Fields:    Translation:Animals
    28. Baudry A, Lamothe B, Bucchini D, Jami J, Montarras D, Pinset C, Joshi RL. IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells. FEBS Lett. 2001 Jan 19; 488(3):174-8. PMID: 11163767.
      Citations: 9     Fields:    Translation:AnimalsCells
    29. Lamothe B, Joshi S. Current developments and future prospects for HIV gene therapy using interfering RNA-based strategies. Front Biosci. 2000 May 01; 5:D527-55. PMID: 10799355.
      Citations: 5     Fields:    Translation:HumansCells
    30. Baudry A, Bucchini D, Deltour L, Desbois P, Durel B, Duvillié B, Jackerott M, Jami J, Joshi RL, Lamothe B, Lamotte L, Cordonnier-Lefort N, Leroux L, Saint Just S. [Insulin and its receptor: lessons learned from the disruption of their gene in mice]. Journ Annu Diabetol Hotel Dieu. 1999; 105-13. PMID: 10732410.
      Citations:    Fields:    Translation:Animals
    31. Lamothe B, Baudry A, Desbois P, Lamotte L, Bucchini D, De Meyts P, Joshi RL. Genetic engineering in mice: impact on insulin signalling and action. Biochem J. 1998 Oct 15; 335 ( Pt 2):193-204. PMID: 9761714.
      Citations: 7     Fields:    Translation:AnimalsCells
    32. Lamothe B, Duvillié B, Cordonnier N, Baudry A, Saint-Just S, Bucchini D, Jami J, Joshi RL. Genetic manipulation of insulin action and beta-cell function in mice. Mol Cell Biochem. 1998 May; 182(1-2):161-8. PMID: 9609125.
      Citations: 1     Fields:    Translation:HumansAnimals
    33. Lamothe B, Baudry A, Christoffersen CT, De Meyts P, Jami J, Bucchini D, Joshi RL. Insulin receptor-deficient cells as a new tool for dissecting complex interplay in insulin and insulin-like growth factors. FEBS Lett. 1998 Apr 24; 426(3):381-5. PMID: 9600271.
      Citations: 6     Fields:    Translation:AnimalsCells
    34. Joshi RL, Lamothe B, Bucchini D, Jami J. Genetically engineered mice as animal models for NIDDM. FEBS Lett. 1997 Jan 20; 401(2-3):99-103. PMID: 9013866.
      Citations: 3     Fields:    Translation:HumansAnimals
    35. Lamothe B, Bucchini D, Jami J, Joshi RL. Reexamining interaction of the SH2 domains of SYP and GAP with insulin and IGF-1 receptors in the two-hybrid system. Gene. 1996 Dec 05; 182(1-2):77-80. PMID: 8982070.
      Citations:    Fields:    Translation:AnimalsCells
    36. Joshi RL, Lamothe B, Cordonnier N, Mesbah K, Monthioux E, Jami J, Bucchini D. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J. 1996 Apr 01; 15(7):1542-7. PMID: 8612577.
      Citations: 68     Fields:    Translation:HumansAnimalsCells
    37. Lamothe B, Bucchini D, Jami J, Joshi RL. Interaction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system. FEBS Lett. 1995 Oct 02; 373(1):51-5. PMID: 7589433.
      Citations: 7     Fields:    Translation:AnimalsCells
    38. Erratum. Proceedings of the National Academy of Sciences of the United States of America. 99:10941.
    39. Carfilzomib triggers cell death in chronic lymphocytic leukemia by inducing proapoptotic and endoplasmic reticulum stress responses. Clinical Cancer Research. 22:4712-4726.
    40. TRAFs in RANK signaling. Advances in Experimental Medicine and Biology. 597:152-159.
    41. Pharmacological and protein profiling suggests venetoclax (ABT-199) as optimal partner with ibrutinib in chronic lymphocytic leukemia. Clinical Cancer Research. 21:3705-3715.
    LAMOTHE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (307)
    Explore
    _
    Co-Authors (19)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _